Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: Permeabilities via diffusion, inside- and outside-directed carrier-mediated transport

Journal of Pharmaceutical Sciences

Volumn 89, Issue 1, 2000, Pages 63-75

  Hilgendorf, Constanze ^a   Spahn Langguth, Hildegard ^a   Regårdh, Carl G ^c   Lipka, Elke ^b   Amidon, Gordon L ^b   Langguth, Peter ^d  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF MICHIGAN   (United States)

^c ASTRAZENECA R AND D   (Sweden)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Biopharmaceutic classification system; Caco 2; Cell culture; Drug transport; HT29 MTX; Intestinal epithelium; Permeability

Indexed keywords

ATENOLOL; CIMETIDINE; DRUG; FUROSEMIDE; GLUCOSE; KETOPROFEN; MANNITOL; METOPROLOL; PHENAZONE; PHENYLALANINE; PIROXICAM; TALINOLOL; TERBUTALINE;

ACTIVE TRANSPORT; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DIFFUSION; DRUG PENETRATION; DRUG TRANSPORT; ELECTROPHYSIOLOGY; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; MODEL; MONOLAYER CULTURE; PASSIVE TRANSPORT;

EID: 0033973754     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6017(200001)89:1<63::AID-JPS7>3.0.CO;2-6     Document Type: Article

References (34)

1. Artursson P. 1991. Cell Cultures as Models for Drug Absorption Across the Intestinal Mucosa. Crit Rev Ther Drug Carrier Syst 8:305-330.
2. Quaroni A, Hochman J. 1996. Development of Intestinal Cell Culture Models for Drug Transport and Metabolism Studies. Adv Drug Del Rev 22: 3-52.
3. Artursson P, Palm K, Luthman K. 1996. Caco-2 Monolayers in Experimental and Theoretical Predictions of Drug Transport. Adv Drug Del Rev 22: 67-84.
4. Madara JL, Trier JS. 1987. Functional Morphology of the Mucosa of the Small Intestine. In: Johnson R, editor. Physiology of the Gastrointestinal Tract, 2nd ed. New York: Raven Press, p 1209-1249.
5. Anderle P, Niederer E, Rubas W, Hilgendorf C, Spahn-Langguth H, Wunderli-Allenspach H, Merkle HP, Langguth P. 1998. P-glycoprotein (P-gp) Mediated Efflux in Caco-2 cell Monolayers: The Influence of Culturing Conditions and Drug Exposure on P-gp Expression Levels. J Pharm Sci 87: 757-762.
6. Huet C, Sahuquillo-Merino C, Coudrier E, Louvard D. 1987. Absorptive and Mucus-Secreting Sub-clones Isolated From a Multipotent Intestinal Cell Line (HT29) Provide New Models for Cell Polarity and Terminal Differentiation. J Cell Biol 105: 345-357.
7. Lesuffleur T, Barbat A, Dussaulx E, Zweibaum A. 1990. Growth Adaptation to Methotrexate of HT-29 Human Colon Carcinoma Cells is Associated with their Ability to Differentiate into Columnar-Absorptive and Mucus-Secreting Cells. Cancer Res 50:6334-6343.
8. Wikman A, Karlsson J, Carlstedt I, Artursson P. 1993. A Drug Absorption Model Based on the Mucus Layer Producing Human Intestinal Goblet Cell Line HT29-H. Pharm Res 10:843-852.
9. Wikman-Larhed A, Artursson P. 1995. Co-Cultures of Human Intestinal Goblet (HT29-H) and Absorptive (Caco-2) Cells for Studies of Drug and Peptide Absorption. Eur. J Pharm Sci 3: 171-193.
10. Walter E, Janich S, Roessler BJ, Hilfinger JM, Amidon GL. 1996. HT29-MTX/Caco-2 Cocultures as an In Vitro Model for the Intestinal Epithelium: In Vitro - In Vivo Correlation With Permeability Data From Rat and Human. J Pharm Sci 4: 1070-1076.
11. Amidon GL, Sinko P, Fleisher D. 1988. Estimating Human Oral Fraction Dose Absorbed: A Correlation Using Rat Intestinal Membrane Permeability for Passive and Carrier-Mediated Compounds. Pharm Res 5:651-654.
12. Lennernäs H, Palm K, Fagerholm U, Artursson P. 1996. Comparison Between Active and Passive Drug Transport in Human Intestinal Epithelial (Caco-2) Cells In Vitro and Human Jejunum In Vivo. Int J Pharm 127:103-107.
13. Ungell A-L, Nylander S, Bergstrand S, Sjöberg A, Lennernäs H. 1998. Membrane Transport of Drugs in Different Regions of the Intestinal Tract of the Rat. J Pharm Sci 87:360-366.
14. Sandzen B, Blom H, Dahlgren S. 1988. Gastric Mucus Layer Thickness Measured by Direct Light Microscopy. Scand. J Gastroenterol 23:1160-1164.
15. Wetterich U, Spahn-Langguth H, Mutschler E, Terhaag B, Rösch W, Langguth P. 1996. Evidence for Intestinal Secretion as an Additional Clearance Pathway of Talinolol Enantiomers: Concentration- and Dose-Dependent Absorption In Vitro and In Vivo. Pharm Res 13:514-522.
16. +-coupled mechanism in cultured renal epithelial monolayers of LLC-PK1 cells. Br J Pharmacol 117: 1139-1144.
17. Artursson P, Magnusson C. 1990. Epithelial Transport of Drugs in Cell Culture. I: A Model for Studying the Passive Diffusion of Drugs Over Intestinal Absorptive (Caco-2) Cells. J Pharm Sci 79:595-600.
18. Hilgers AR, Conradi RA, Burton PS. 1990. Caco-2 Cell Monolayers as a Model for Drug Transport Across the Intestinal Mucosa. Pharm Res 7: 902-910.
19. Wilson G, Hassan IF, Dix CJ, Williamson I, Shah R, Mackay M, Artursson P. 1990. Transport and Permeability Properties of Human Caco-2 Cells: An In Vitro Model of the Intestinal Epithelial Cell Barrier. J Contr Rel 11:25-40.
20. Hidalgo IJ, Raub TJ, Borchardt RT. 1989. Characterization of the Human Colon Carcinoma Cell Line (Caco-2) as a Model System for Intestinal Epithelial Permeability. Gastroenterol 96:736-749.
21. Karlsson J, Wikman A, Artursson P. 1993. The Mucus Layer as a Barrier to Drug Absorption in Monolayers of Human Intestinal Epithelial HT29-H Goblet Cells. Int J Pharm 99:209-218.
22. Wikman-Larhed A, Artursson P, Björk E. 1998. The Influence of Intestinal Mucus Components on the Diffusion of Drugs. Pharm Res 15:66-71.
23. Burton PS, Conradi RA, Hilgers AR, Ho NFH. 1993. Evidence For a Polarized Efflux System for Peptides in the Apical Membrane of Caco-2 Cells. Biochem Biophys Res Commun 190:760-766.
24. Sadée W, Drübbisch V, Amidon GL. 1995. Biology of Membrane Transport Proteins. Pharm Res 12: 1823-1837.
25. Artursson P, Karlsson J. 1991. Correlation Between Oral Drug Absorption in Humans and Apparent Drug Permeability Coefficient in Human Intestinal Epithelial (Caco-2) Cells. Biochem Biophys Res Comm 175:880-885.
26. Hunter J, Hirst BH, Simmons NL. 1993. Drug Absorption Limited by P-glycoprotein-Mediated Secretory Drug Transport in Human Intestinal Epithelial Caco-2 Cell Layers. Pharm Res 10:743-749.
27. Hunter J, Jepson MA, Tsuruo T, Simmons NL, Hirst BH. 1993. Functional Expression of P-glycoprotein in Apical Membrane of Human Intestinal Caco-2 Cells. J Biol Chem 268:14991-14997.
28. Nuttal J, Horspool KR. Implications of P-gp Expression in Caco-2 Cell Monolayers on Prediction of Drug Absorption In Vivo. Workshop on Strategies on Oral Drug Delivery, Ascona, ETH Zurich, May 1996.
29. Hunter J, Hirst BH. 1997. Intestinal Secretion of Drugs. The Role of P-glycoprotein and Related Drug Efflux Systems in Limiting Oral Drug Absorption. Adv Drug Delivery Rev 25:129-158.
30. Meunier V, Bourrie M, Berger Y, Fabre G. 1995. The Human Intestinal Epithelial Cell Line Caco-2: Pharmacological and Pharmacokinetic Applications. Cell Biol Toxicol 11:187-194.
31. Peters WHM, Boon CEW, Roelofs HMJ, Wobbes T, Nagengast FM, Kremers PG. 1992. Expression of Drug-Metabolizing Enzymes and P-170 Glycoprotein In Colorectal Carcinoma and Normal Mucosa. Gastroenterol 103:448-455.
32. Sakai M, Noach ABJ, Blom-Roosemalen MCM, de Boer AG, Breimer DD. 1994. Absorption Enhancement of Hydrophilic Compounds by Verapamil in Caco-2 Cell Monolayers. Biochem Pharmacol 48: 1199-1210.
33. Terao T, Hisanaga E, Sai Y, Tamai I, Tsuji A. 1996. Active Secretion of Drugs From the Small Intestinal Epithelium of Rats by P-glycoprotein Functioning as an Absorption Barrier. J Pharm Pharmacol 48:1083-1089.
34. Matthes I, Nimmerfall F, Sucker H. 1992. Mukusmodelle zur Untersuchung von intestinalen Absorptionsmechanismen. 1. Mitt.: Validierung und Optimierung der Modelle. Pharmazie 47:505-515.